- Home
- WSC vs CPRX Comparison
WSC vs CPRX Comparison
Compare WSC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WSC | CPRX |
|---|---|---|
| Founded | 1944 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | WSC | CPRX |
|---|---|---|
| Price | $22.90 | $29.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $24.14 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.2M | 1.6M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | N/A | ★ 28.24 |
| EPS | N/A | ★ 1.68 |
| Revenue | ★ $2,281,446,000.00 | $119,072,803.00 |
| Revenue This Year | N/A | $9.20 |
| Revenue Next Year | $3.31 | $10.51 |
| P/E Ratio | ★ N/A | $17.54 |
| Revenue Growth | N/A | ★ 16.39 |
| 52 Week Low | $14.91 | $19.05 |
| 52 Week High | $31.88 | $32.56 |
Technical Indicators
Market Signals| Indicator | WSC | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 75.50 | 75.03 |
| Support Level | $21.06 | $22.41 |
| Resistance Level | $24.87 | N/A |
| Average True Range (ATR) | 0.89 | 1.18 |
| MACD | 0.46 | 0.36 |
| Stochastic Oscillator | 90.81 | 61.12 |
Price Performance
Historical ComparisonAbout WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services on-site, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company include modular office complexes, mobile offices, classrooms, blast-resistant modules, clearspan structures, sanitation solutions, portable storage containers, and climate-controlled containers and trailers.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.